Editorial
doi: 10.1183/13993003.00361-2021.
Print 2021 Apr.
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
Affiliations
- PMID: 33833074
- DOI: 10.1183/13993003.00361-2021
Item in Clipboard
Editorial
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
Eur Respir J.
.
Free article
No abstract available
Conflict of interest statement
Conflict of interest: N.N. Linh has nothing to disclose. Conflict of interest: M. Gegia has nothing to disclose. Conflict of interest: M. Zignol has nothing to disclose. Conflict of interest: P. Glaziou has nothing to disclose. Conflict of interest: N. Ismail has nothing to disclose. Conflict of interest: T. Kasaeva has nothing to disclose. Conflict of interest: F. Mirzayev has nothing to disclose. Conflict of interest: K. Viney has nothing to disclose.
Comment in
-
Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?Eur Respir J. 2021 Jul 1;58(1):2100959. doi: 10.1183/13993003.00959-2021. Print 2021 Jul. Eur Respir J. 2021. PMID: 34215664 No abstract available.
Similar articles
-
Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.Clin Microbiol Infect. 2017 Dec;23(12):1002-1004. doi: 10.1016/j.cmi.2017.07.002. Epub 2017 Jul 8. Clin Microbiol Infect. 2017. PMID: 28698038 No abstract available.
-
WHO strategies for the management of drug-resistant tuberculosis.Arch Bronconeumol. 2017 Mar;53(3):95-97. doi: 10.1016/j.arbres.2016.07.015. Epub 2016 Oct 4. Arch Bronconeumol. 2017. PMID: 27717622 English, Spanish. No abstract available.
-
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?Indian J Med Res. 2019 Mar;149(3):309-312. doi: 10.4103/ijmr.IJMR_579_19. Indian J Med Res. 2019. PMID: 31249191 Free PMC article. No abstract available.
-
Management of multidrug resistant tuberculosis.Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460005 Review.
-
Drug resistant tuberculosis: Current scenario and impending challenges.Indian J Tuberc. 2022 Apr;69(2):227-233. doi: 10.1016/j.ijtb.2021.04.008. Epub 2021 Apr 20. Indian J Tuberc. 2022. PMID: 35379406 Review.
Cited by
-
Mapping the Evolution of Clinical Trials on Drug-Resistant Tuberculosis: A Bibliometric Overview (1965-2023).Cureus. 2024 Feb 28;16(2):e55190. doi: 10.7759/cureus.55190. eCollection 2024 Feb. Cureus. 2024. PMID: 38425326 Free PMC article. Review.
-
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis.Front Med (Lausanne). 2024 Jan 10;10:1304857. doi: 10.3389/fmed.2023.1304857. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38274444 Free PMC article. Review.
-
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and Challenges.Pathogens. 2023 Dec 27;13(1):27. doi: 10.3390/pathogens13010027. Pathogens. 2023. PMID: 38251335 Free PMC article. Review.
-
Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis.J Clin Tuberc Other Mycobact Dis. 2023 Dec 1;34:100405. doi: 10.1016/j.jctube.2023.100405. eCollection 2024 Feb. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 38152568 Free PMC article. Review.
-
Extrapulmonary and Drug-Resistant Childhood Tuberculosis: Unveiling the Disease to Adopt the Optimal Treatment Strategy.Pathogens. 2023 Dec 12;12(12):1439. doi: 10.3390/pathogens12121439. Pathogens. 2023. PMID: 38133322 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
